Revaluation of chloroquine therapeutic efficacy on children with uncomplicated Plasmodium falciparum malaria in eastern Ivory Coast (1999-2002)

被引：1

作者：

Adoubryn, KD ^{[1
]}

Ouhon, J ^{[1
]}

Yapo, CG ^{[1
]}

N'guettia, KS ^{[1
]}

Kouakou, KAE ^{[1
]}

Adou, SJ ^{[1
]}

Kouabenan, A ^{[1
]}

Assoumou, A ^{[1
]}

机构：

[1] UFR Sci Med, Lab Parasitol Mycol, Abidjan, Cote Ivoire

来源：

MEDECINE ET MALADIES INFECTIEUSES | 2004年 / 34卷 / 03期

关键词：

chloroquine; malaria; Plasmodium falciparum;

D O I：

10.1016/j.medmal.2003.11.004

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Objective. - A prospective study was made from November 1999 to May 2002 in order to revaluate the therapeutic efficacy of chloroquine in pediatric Plamodium falciparum malaria in Ivory Coast. Design. - This study was included in the national Plasmodium falciparum-susceptibility supervision program. Two hundred and fifty-six out of 594 patients from six to 59 months of age were included. Chloroquine was administered in accordance with the standard 14 day WHO protocol; i.e. administered dose of 25 mg/kg, in split doses, over three days. Results. - Two hundred and forty-seven patients completed the treatment. Among these, 217 presented with adequate clinical response (87.8%). The percentage of therapeutic failure was 12.2% with 12 early cases of therapeutic failure and 18 late cases of therapeutic failure. Chloroquine was more efficacious in Agnibilekrou (11.3% of therapeutic failure), Bondoukou (10.4%), and Tanda (10%), than in Abengourou (16.4%). Parasitic reduction on patients with resistant Plasmodium was superior to 90%, from day 0 to day 3. The risk of therapeutic failure was significantly linked to patient age. Conclusion. - Considering these results, the authors suggest that the first-line treatment with chloroquine must be continued for uncomplicated malaria in humans. (C) 2003 Elsevier SAS. Tons droits reserves.

引用

页码：127 / 131

页数：5

共 14 条

[1] ADJETEY TAK, 1997, MALARIA, V6, P24
[2] In vivo Plasmodium falciparum sensitivity to chloroquine in humans (Ivory Coast).
Adou-Bryn, KD
Memain, SD
Ouhon, J
Assoumou, A
Kone, M
[J]. MEDECINE ET MALADIES INFECTIEUSES, 1999, 29 (07): : 476 - 479
[3] Adou-Bryn KD, 2002, B SOC PATHOL EXOT, V95, P262
[4] Amat-Roze J.M., 1982, Medecine Tropicale, V42, P383
[5] Henry M. C., 1998, Cahiers d'Etudes et de Recherches Francophones/Sante, V8, P287
[6] Henry M C, 2002, Med Trop (Mars), V62, P55
[7] IN-VIVO SENSITIVITY OF PLASMODIUM-FALCIPARUM TO CHLOROQUINE IN RURAL-AREAS OF COTE-DIVOIRE
HENRY, MC
VANLEEUWEN, WD
WATSON, P
JANSEN, A
JACOBS, K
ZWART, F
AGRICOLA, K
NAHOUNOU, N
DOSSOU, J
EGGELTE, TE
[J]. ACTA TROPICA, 1994, 58 (3-4) : 275 - 281
[8] Henry MC, 1996, TROP MED INT HEALTH, V1, P610
[9] KONE M, 1990, B SOC PATHOL EXOT, V83, P187
[10] *OMS, 1996, MAL, V1077, P1

← 1 2 →